Helix BioMedix, Inc. (HXBM)
USD 7.18
(0.0%)
USD 7.18
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.97 Million USD | -30.02% |
| 2022 | 2.81 Million USD | 0.0% |
| 2011 | 3.45 Million USD | 0.57% |
| 2010 | 3.43 Million USD | 4.62% |
| 2009 | 3.28 Million USD | -11.72% |
| 2008 | 3.71 Million USD | 1.31% |
| 2007 | 3.66 Million USD | 1.13% |
| 2006 | 3.62 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 FY | 1.97 Million USD | -30.02% |
| 2022 FY | 2.81 Million USD | 0.0% |
| 2011 FY | 3.45 Million USD | 0.57% |
| 2010 FY | 3.43 Million USD | 4.62% |
| 2009 FY | 3.28 Million USD | -11.72% |
| 2008 FY | 3.71 Million USD | 1.31% |
| 2007 FY | 3.66 Million USD | 1.13% |
| 2006 FY | 3.62 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -47.67% |
| Arch Therapeutics, Inc. | 5.04 Million USD | 60.888% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 93.327% |
| Nascent Biotech, Inc. | 2.22 Million USD | 11.563% |
| Rebus Holdings, Inc. | 664 Thousand USD | -196.993% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 94.707% |
| Qrons Inc. | 643.67 Thousand USD | -206.37% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -406.213% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 96.567% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -374.641% |
| Skye Bioscience, Inc. | 13.54 Million USD | 85.444% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 97.728% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 59.901% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -653.473% |
| SQZ Biotechnologies Company | 85.61 Million USD | 97.697% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | 32.377% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -31.303% |
| Mesoblast Limited | 5.9 Million USD | 66.587% |
| Marizyme, Inc. | 19.23 Million USD | 89.75% |
| Genus plc | 147.7 Million USD | 98.665% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 77.538% |
| Pharming Group N.V. | 225.49 Million USD | 99.125% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | 3.742% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -46.997% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 76.352% |
| ContraFect Corporation | 56.88 Million USD | 96.534% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | 55.269% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -33.358% |
| IMV Inc. | 37.7 Million USD | 94.77% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | 29.327% |
| MultiCell Technologies, Inc. | 567.42 USD | -347443.971% |
| ONE Bio Corp. | 6.44 Million USD | 69.397% |
| Accustem Sciences Inc. | 3.74 Million USD | 47.362% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 97.705% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -270.71% |
| Q BioMed Inc. | 3.43 Million USD | 42.617% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 92.021% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | 24.947% |
| Biomind Labs Inc. | 994.18 Thousand USD | -98.357% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 98.015% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -12.068% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 70.646% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -5.775% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 7988.136% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 87.683% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -7.462% |
| GB Sciences, Inc. | 1.42 Million USD | -38.826% |
| Alpha Cognition Inc. | 9.7 Million USD | 79.681% |
| HST Global, Inc. | 140.9 Thousand USD | -1299.529% |
| CSL Limited | 3.44 Billion USD | 99.943% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -75.306% |
| Halberd Corporation | 74.84 Thousand USD | -2534.93% |
| Enzolytics Inc. | 2.17 Million USD | 9.519% |
| Agentix Corp. | 1.37 Million USD | -43.76% |
| Resverlogix Corp. | 12.71 Million USD | 84.487% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | 45.982% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 99.871% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -88.892% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | 18.0% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -24.863% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | 42.084% |
| AVAX Technologies, Inc. | 7.31 Million USD | 73.024% |
| Zenith Capital Corp. | 8.94 Million USD | 77.949% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.761% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -11219.867% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | 19.683% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -1049.814% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -2.662% |
| Kadimastem Ltd | 2.41 Million USD | 18.177% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 81.853% |
| BioStem Technologies, Inc. | 22.97 Million USD | 91.417% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -986.61% |
| LadRx Corporation | 3.81 Million USD | 48.265% |
| Cell Source, Inc. | 4.32 Million USD | 54.407% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -113.537% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -113.537% |
| NovAccess Global Inc. | 2.46 Million USD | 20.056% |
| Affymax, Inc. | 39.38 Million USD | 94.993% |
| Itoco Inc. | 919.14 Thousand USD | -114.551% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | 53.472% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -76.232% |
| Mobile Lads Corp. | 554.54 Thousand USD | -255.612% |
| CytoDyn Inc. | 18.05 Million USD | 89.079% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -7735.17% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -796.061% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -38.896% |
| SYBLEU INC | 160.87 Thousand USD | -1125.81% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -8.573% |
| International Stem Cell Corporation | 5.27 Million USD | 62.587% |
| Bioxytran, Inc. | 3.82 Million USD | 48.378% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -3646.123% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -9593.919% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 94.562% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -21.881% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -167.999% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | 36.611% |
| Neutra Corp. | 243.82 Thousand USD | -708.804% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 88.703% |
| PureTech Health plc | 144.59 Million USD | 98.636% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 90.376% |
| IXICO plc | 4.7 Million USD | 58.104% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 77.583% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 98.325% |
| CSL Limited | 3.89 Billion USD | 99.949% |
| Cellectis S.A. | 97.32 Million USD | 97.974% |